Costs of needlestick injuries and subsequent hepatitis and HIV infection

J Paul Leigh, Marion Gillen, Peter Franks, Susan Sutherland, Hien H Nguyen, Kyle Steenland, Guibo Xing

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Physicians, nurses and other healthcare workers (HCWs) are at risk of bloodborne pathogens infection from needlestick injuries, but costs of needlesticks are little studied. Methods: We used the cost-of-illness and incidence approaches. We used the perspective of the medical provider (medical costs) and the individual (lost productivity). Data on needlesticks, infections from hepatitis B and C (HBV, HCV) and human immune-deficiency (HIV) among HCWs, as well as data on per-unit costs were culled from research literature, Centers for Disease Control and Prevention reports, and Bureau of Labor Statistics reports. We also generated estimates based upon industry employment and scenarios for source-patients. These data and estimates were combined with assumptions to produce a model that generated base-case estimates as well as one-way and multi-way probabilistic sensitivity analyses. Future costs were discounted by 3%. Results: We estimated 644963 needlesticks in the healthcare industry for 2004 of which 49% generated costs. Medical costs were $107.3 million of which 96% resulted from testing and prophylaxis and 4% from treating long-term infections (34 persons with chronic HBV, 143 with chronic HCV, and 1 with HIV). Lost-work productivity generated $81.2 million, for which 59% involved testing and prophylaxis and 41% involved long-term infections. Combined medical and work productivity costs summed to $188.5 million. Multi-way sensitivity analysis suggested a range on combined costs from $100.7 million to $405.9 million. Conclusion: Detailed methodology was developed to estimate costs of needlesticks and subsequent infections for hospital-based and non-hospital-based health care workers. The combined medical and lost productivity costs comprised roughly 0.1% of all occupational injury and illness costs for all jobs in the economy. We did not account for lost home production or pain and suffering costs, however, nor did we estimate benefit/cost ratios of specific interventions to reduce needlesticks.

Original languageEnglish (US)
Pages (from-to)2093-2105
Number of pages13
JournalCurrent Medical Research and Opinion
Volume23
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Needlestick Injuries
Hepatitis
HIV Infections
Costs and Cost Analysis
Infection
Delivery of Health Care
Blood-Borne Pathogens
Occupational Injuries
Cost of Illness
Health Care Sector
Occupational Diseases
Centers for Disease Control and Prevention (U.S.)
Hepatitis C
Cross Infection
Hepatitis B
Cost-Benefit Analysis
HIV-1
Industry

Keywords

  • Bloodborne pathogens
  • Job-related
  • Occupation
  • Percutaneous injuries

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Costs of needlestick injuries and subsequent hepatitis and HIV infection. / Leigh, J Paul; Gillen, Marion; Franks, Peter; Sutherland, Susan; Nguyen, Hien H; Steenland, Kyle; Xing, Guibo.

In: Current Medical Research and Opinion, Vol. 23, No. 9, 09.2007, p. 2093-2105.

Research output: Contribution to journalArticle

Leigh, J Paul ; Gillen, Marion ; Franks, Peter ; Sutherland, Susan ; Nguyen, Hien H ; Steenland, Kyle ; Xing, Guibo. / Costs of needlestick injuries and subsequent hepatitis and HIV infection. In: Current Medical Research and Opinion. 2007 ; Vol. 23, No. 9. pp. 2093-2105.
@article{254131ee7921442eafb70b7d92a0acde,
title = "Costs of needlestick injuries and subsequent hepatitis and HIV infection",
abstract = "Background: Physicians, nurses and other healthcare workers (HCWs) are at risk of bloodborne pathogens infection from needlestick injuries, but costs of needlesticks are little studied. Methods: We used the cost-of-illness and incidence approaches. We used the perspective of the medical provider (medical costs) and the individual (lost productivity). Data on needlesticks, infections from hepatitis B and C (HBV, HCV) and human immune-deficiency (HIV) among HCWs, as well as data on per-unit costs were culled from research literature, Centers for Disease Control and Prevention reports, and Bureau of Labor Statistics reports. We also generated estimates based upon industry employment and scenarios for source-patients. These data and estimates were combined with assumptions to produce a model that generated base-case estimates as well as one-way and multi-way probabilistic sensitivity analyses. Future costs were discounted by 3{\%}. Results: We estimated 644963 needlesticks in the healthcare industry for 2004 of which 49{\%} generated costs. Medical costs were $107.3 million of which 96{\%} resulted from testing and prophylaxis and 4{\%} from treating long-term infections (34 persons with chronic HBV, 143 with chronic HCV, and 1 with HIV). Lost-work productivity generated $81.2 million, for which 59{\%} involved testing and prophylaxis and 41{\%} involved long-term infections. Combined medical and work productivity costs summed to $188.5 million. Multi-way sensitivity analysis suggested a range on combined costs from $100.7 million to $405.9 million. Conclusion: Detailed methodology was developed to estimate costs of needlesticks and subsequent infections for hospital-based and non-hospital-based health care workers. The combined medical and lost productivity costs comprised roughly 0.1{\%} of all occupational injury and illness costs for all jobs in the economy. We did not account for lost home production or pain and suffering costs, however, nor did we estimate benefit/cost ratios of specific interventions to reduce needlesticks.",
keywords = "Bloodborne pathogens, Job-related, Occupation, Percutaneous injuries",
author = "Leigh, {J Paul} and Marion Gillen and Peter Franks and Susan Sutherland and Nguyen, {Hien H} and Kyle Steenland and Guibo Xing",
year = "2007",
month = "9",
doi = "10.1185/030079907X219517",
language = "English (US)",
volume = "23",
pages = "2093--2105",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Costs of needlestick injuries and subsequent hepatitis and HIV infection

AU - Leigh, J Paul

AU - Gillen, Marion

AU - Franks, Peter

AU - Sutherland, Susan

AU - Nguyen, Hien H

AU - Steenland, Kyle

AU - Xing, Guibo

PY - 2007/9

Y1 - 2007/9

N2 - Background: Physicians, nurses and other healthcare workers (HCWs) are at risk of bloodborne pathogens infection from needlestick injuries, but costs of needlesticks are little studied. Methods: We used the cost-of-illness and incidence approaches. We used the perspective of the medical provider (medical costs) and the individual (lost productivity). Data on needlesticks, infections from hepatitis B and C (HBV, HCV) and human immune-deficiency (HIV) among HCWs, as well as data on per-unit costs were culled from research literature, Centers for Disease Control and Prevention reports, and Bureau of Labor Statistics reports. We also generated estimates based upon industry employment and scenarios for source-patients. These data and estimates were combined with assumptions to produce a model that generated base-case estimates as well as one-way and multi-way probabilistic sensitivity analyses. Future costs were discounted by 3%. Results: We estimated 644963 needlesticks in the healthcare industry for 2004 of which 49% generated costs. Medical costs were $107.3 million of which 96% resulted from testing and prophylaxis and 4% from treating long-term infections (34 persons with chronic HBV, 143 with chronic HCV, and 1 with HIV). Lost-work productivity generated $81.2 million, for which 59% involved testing and prophylaxis and 41% involved long-term infections. Combined medical and work productivity costs summed to $188.5 million. Multi-way sensitivity analysis suggested a range on combined costs from $100.7 million to $405.9 million. Conclusion: Detailed methodology was developed to estimate costs of needlesticks and subsequent infections for hospital-based and non-hospital-based health care workers. The combined medical and lost productivity costs comprised roughly 0.1% of all occupational injury and illness costs for all jobs in the economy. We did not account for lost home production or pain and suffering costs, however, nor did we estimate benefit/cost ratios of specific interventions to reduce needlesticks.

AB - Background: Physicians, nurses and other healthcare workers (HCWs) are at risk of bloodborne pathogens infection from needlestick injuries, but costs of needlesticks are little studied. Methods: We used the cost-of-illness and incidence approaches. We used the perspective of the medical provider (medical costs) and the individual (lost productivity). Data on needlesticks, infections from hepatitis B and C (HBV, HCV) and human immune-deficiency (HIV) among HCWs, as well as data on per-unit costs were culled from research literature, Centers for Disease Control and Prevention reports, and Bureau of Labor Statistics reports. We also generated estimates based upon industry employment and scenarios for source-patients. These data and estimates were combined with assumptions to produce a model that generated base-case estimates as well as one-way and multi-way probabilistic sensitivity analyses. Future costs were discounted by 3%. Results: We estimated 644963 needlesticks in the healthcare industry for 2004 of which 49% generated costs. Medical costs were $107.3 million of which 96% resulted from testing and prophylaxis and 4% from treating long-term infections (34 persons with chronic HBV, 143 with chronic HCV, and 1 with HIV). Lost-work productivity generated $81.2 million, for which 59% involved testing and prophylaxis and 41% involved long-term infections. Combined medical and work productivity costs summed to $188.5 million. Multi-way sensitivity analysis suggested a range on combined costs from $100.7 million to $405.9 million. Conclusion: Detailed methodology was developed to estimate costs of needlesticks and subsequent infections for hospital-based and non-hospital-based health care workers. The combined medical and lost productivity costs comprised roughly 0.1% of all occupational injury and illness costs for all jobs in the economy. We did not account for lost home production or pain and suffering costs, however, nor did we estimate benefit/cost ratios of specific interventions to reduce needlesticks.

KW - Bloodborne pathogens

KW - Job-related

KW - Occupation

KW - Percutaneous injuries

UR - http://www.scopus.com/inward/record.url?scp=36049038256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36049038256&partnerID=8YFLogxK

U2 - 10.1185/030079907X219517

DO - 10.1185/030079907X219517

M3 - Article

C2 - 17655812

AN - SCOPUS:36049038256

VL - 23

SP - 2093

EP - 2105

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 9

ER -